The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 26, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
Level 1 |
|
Level 2 |
|
|
|
Total |
Assets: |
|
|
|
|
|
|
|
Cash equivalents |
$ |
0.3 |
|
|
$ |
— |
|
|
|
|
$ |
0.3
|
|
Short-term investments in marketable securities |
0.8 |
|
|
— |
|
|
|
|
0.8
|
|
Restricted cash |
9.1 |
|
|
— |
|
|
|
|
9.1
|
|
Derivatives |
— |
|
|
2.6 |
|
|
|
|
2.6
|
|
Total assets |
$ |
10.2 |
|
|
$ |
2.6 |
|
|
|
|
$ |
12.8
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
Derivatives |
$ |
— |
|
|
$ |
3.7 |
|
|
|
|
$ |
3.7
|
|
Deferred compensation |
0.8 |
|
|
16.5 |
|
|
|
|
17.3
|
|
Total liabilities at fair value |
$ |
0.8 |
|
|
$ |
20.2 |
|
|
|
|
$ |
21.0
|
|
Liabilities measured at net asset value |
|
|
|
|
|
|
10.1
|
|
Total liabilities |
|
|
|
|
|
|
$ |
31.1
|
|
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
Level 1 |
|
Level 2 |
|
|
|
Total |
Assets: |
|
|
|
|
|
|
|
Cash equivalents |
$ |
0.3 |
|
|
$ |
— |
|
|
|
|
$ |
0.3
|
|
Short-term investments in marketable securities |
0.8 |
|
|
— |
|
|
|
|
0.8
|
|
Restricted cash |
11.6 |
|
|
— |
|
|
|
|
11.6
|
|
Derivatives |
— |
|
|
4.2 |
|
|
|
|
4.2
|
|
Total assets |
$ |
12.7 |
|
|
$ |
4.2 |
|
|
|
|
$ |
16.9
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
Derivatives |
$ |
— |
|
|
$ |
3.2 |
|
|
|
|
$ |
3.2
|
|
Deferred compensation |
1.2 |
|
|
18.8 |
|
|
|
|
20.0
|
|
Total liabilities at fair value |
$ |
1.2 |
|
|
$ |
22.0 |
|
|
|
|
$ |
23.2
|
|
Liabilities measured at net asset value |
|
|
|
|
|
|
8.5
|
|
Total liabilities |
|
|
|
|
|
|
$ |
31.7
|
|
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 28, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions) |
Level 1 |
|
Level 2 |
|
|
|
Total |
Assets: |
|
|
|
|
|
|
|
Cash equivalents |
$ |
0.2 |
|
|
$ |
— |
|
|
|
|
$ |
0.2
|
|
Short-term investments in marketable securities |
0.8 |
|
|
— |
|
|
|
|
0.8
|
|
Restricted cash |
11.6 |
|
|
— |
|
|
|
|
11.6
|
|
Derivatives |
— |
|
|
11.7 |
|
|
|
|
11.7
|
|
Total assets |
$ |
12.6 |
|
|
$ |
11.7 |
|
|
|
|
$ |
24.3
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
Derivatives |
$ |
— |
|
|
$ |
1.8 |
|
|
|
|
$ |
1.8
|
|
Deferred compensation |
1.1 |
|
|
20.6 |
|
|
|
|
21.7
|
|
Total liabilities at fair value |
$ |
1.1 |
|
|
$ |
22.4 |
|
|
|
|
$ |
23.5
|
|
Liabilities measured at net asset value |
|
|
|
|
|
|
10.3
|
|
Total liabilities |
|
|
|
|
|
|
$ |
33.8
|
|
|